Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-58.26	79.12	189.56
Graham Fair Price	8.26	0.98	0.90
PEG	-81.03	0.25	-1.32
Price/Book	-53.19	1.93	4.13
Price/Cash Flow	-34.80	26.24	-40.25
Prices/Earnings	-60.78	-54.89	139.94
Price/Sales	-62.54	2.79	7.46
Price/FCF	-34.80	26.24	-40.25
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.92	0.12	0.12
Operating Margin	209.21	0.02	< 0.005
ROA	23.82	< 0.005	< 0.005
ROE	< 0.005	< 0.005	19.34
ROIC	< 0.005	< 0.005	-85.62
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.02	0.12	-84.58
Dividends QOQ	-0.18	-0.12	34.44
EBIT QOQ	0.88	4.83	448.94
EPS QOQ	1.06	-2.18	106.78
FCF QOQ	-1.38	1.71	24.40
Revenue QOQ	-0.24	0.24	-1.20
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	171.52	111.40	-35.05
Days Sales Outstanding (DSO)	208.30	179.30	-13.92
Inventory Turnover	0.52	0.81	53.97
Debt/Capitalization	0.65	0.64	-0.22
Quick Ratio	0.96	1.01	5.60
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	2.21	2.83	28.04
Cash	1.47	0.79	-46.33
Capex	-0.03	0.02	-25.08
Free Cash Flow	-0.23	0.16	-28.85
Revenue	1.23	1.52	23.84
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.51	1.41	-6.45
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	44.05	35.01	-20.53
Naive Interpretation	Member

06 - Financial Health · Weak

Rating